Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Aurélie Pétain being referenced
315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody
2020
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aurélie Pétain | 123 | 97 | 35 | 131 | 18 | 313 | |
| John N. Bickers | 83 | 133 | 17 | 142 | 17 | 366 | |
| Alan Fotoohi | 75 | 108 | 16 | 53 | 17 | 354 | |
| Britt Sundman‐Engberg | 181 | 158 | 13 | 119 | 19 | 341 | |
| Yusuke Hara | 78 | 187 | 27 | 133 | 28 | 371 | |
| Jason Law | 55 | 90 | 29 | 71 | 18 | 350 | |
| Miguel Franquiz | 57 | 74 | 25 | 187 | 11 | 262 | |
| Donald M. Hayes | 77 | 71 | 22 | 94 | 21 | 286 | |
| J Janssen | 179 | 80 | 34 | 106 | 14 | 324 | |
| Charlene M. McShane | 67 | 81 | 40 | 71 | 26 | 314 | |
| Stefania Crisci | 84 | 130 | 33 | 51 | 27 | 306 |
All Works
Loading papers...